At meeting held on 21 August 2017
The Board of Biocon at its meeting held on 21 August 2017 has approved the following -Transfer of Biosimilars business of the Company by way of a slump sale as 'going concern' to Biocon Biologics India, a step down subsidiary of the Company subject to approval of shareholders of the company and other statutory and regulatory approvals.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
